Home Healthcare Biotechnology Lung Cancer Genomic Testing Market

Lung Cancer Genomic Testing Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Reagents & Consumables, Services), By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Microarray, Others), By Sample Type (Tissue Biopsy, Liquid Biopsy), By Panel Type (Multi Gene Panel, Single Gene Panel), By End User (Hospitals, Cancer Centers, Diagnostic Laboratories, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 30, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Lung Cancer Genomic Testing Market, By Product & Service 2022-2034 (USD MILLION/ Units)
    1. Instruments
    2. Reagents & Consumables
    3. Services
  2. Lung Cancer Genomic Testing Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Next Generation Sequencing
    2. Polymerase Chain Reaction
    3. Fluorescence In Situ Hybridization
    4. Microarray
    5. Others
  3. Lung Cancer Genomic Testing Market, By Sample Type 2022-2034 (USD MILLION/ Units)
    1. Tissue Biopsy
    2. Liquid Biopsy
  4. Lung Cancer Genomic Testing Market, By Panel Type 2022-2034 (USD MILLION/ Units)
    1. Multi Gene Panel
    2. Single Gene Panel
  5. Lung Cancer Genomic Testing Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Cancer Centers
    3. Diagnostic Laboratories
    4. Others
  6. Regional Lung Cancer Genomic Testing Market
    1. North America
      1. North America Lung Cancer Genomic Testing Market By Product & Service 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents & Consumables
        3. Services
      2. North America Lung Cancer Genomic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next Generation Sequencing
        2. Polymerase Chain Reaction
        3. Fluorescence In Situ Hybridization
        4. Microarray
        5. Others
      3. North America Lung Cancer Genomic Testing Market By Sample Type 2022-2034 (USD MILLION/ Units)
        1. Tissue Biopsy
        2. Liquid Biopsy
      4. North America Lung Cancer Genomic Testing Market By Panel Type 2022-2034 (USD MILLION/ Units)
        1. Multi Gene Panel
        2. Single Gene Panel
      5. North America Lung Cancer Genomic Testing Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Centers
        3. Diagnostic Laboratories
        4. Others
      6. U.S.
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      7. Canada
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
    2. Europe
      1. Europe Lung Cancer Genomic Testing Market By Product & Service 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents & Consumables
        3. Services
      2. Europe Lung Cancer Genomic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next Generation Sequencing
        2. Polymerase Chain Reaction
        3. Fluorescence In Situ Hybridization
        4. Microarray
        5. Others
      3. Europe Lung Cancer Genomic Testing Market By Sample Type 2022-2034 (USD MILLION/ Units)
        1. Tissue Biopsy
        2. Liquid Biopsy
      4. Europe Lung Cancer Genomic Testing Market By Panel Type 2022-2034 (USD MILLION/ Units)
        1. Multi Gene Panel
        2. Single Gene Panel
      5. Europe Lung Cancer Genomic Testing Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Centers
        3. Diagnostic Laboratories
        4. Others
      6. U.K.
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      7. Germany
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      8. France
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      9. Spain
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      10. Italy
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      11. Russia
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      12. Nordic
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      13. Benelux
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      14. Rest of Europe
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
    3. APAC
      1. APAC Lung Cancer Genomic Testing Market By Product & Service 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents & Consumables
        3. Services
      2. APAC Lung Cancer Genomic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next Generation Sequencing
        2. Polymerase Chain Reaction
        3. Fluorescence In Situ Hybridization
        4. Microarray
        5. Others
      3. APAC Lung Cancer Genomic Testing Market By Sample Type 2022-2034 (USD MILLION/ Units)
        1. Tissue Biopsy
        2. Liquid Biopsy
      4. APAC Lung Cancer Genomic Testing Market By Panel Type 2022-2034 (USD MILLION/ Units)
        1. Multi Gene Panel
        2. Single Gene Panel
      5. APAC Lung Cancer Genomic Testing Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Centers
        3. Diagnostic Laboratories
        4. Others
      6. China
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      7. Korea
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      8. Japan
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      9. India
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      10. Australia
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      11. Singapore
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      12. Taiwan
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      13. South East Asia
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      14. Rest of Asia-Pacific
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
    4. Middle East and Africa
      1. Middle East and Africa Lung Cancer Genomic Testing Market By Product & Service 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents & Consumables
        3. Services
      2. Middle East and Africa Lung Cancer Genomic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next Generation Sequencing
        2. Polymerase Chain Reaction
        3. Fluorescence In Situ Hybridization
        4. Microarray
        5. Others
      3. Middle East and Africa Lung Cancer Genomic Testing Market By Sample Type 2022-2034 (USD MILLION/ Units)
        1. Tissue Biopsy
        2. Liquid Biopsy
      4. Middle East and Africa Lung Cancer Genomic Testing Market By Panel Type 2022-2034 (USD MILLION/ Units)
        1. Multi Gene Panel
        2. Single Gene Panel
      5. Middle East and Africa Lung Cancer Genomic Testing Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Centers
        3. Diagnostic Laboratories
        4. Others
      6. UAE
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      7. Turkey
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      8. Saudi Arabia
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      9. South Africa
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      10. Egypt
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      11. Nigeria
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      12. Rest of MEA
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
    5. LATAM
      1. LATAM Lung Cancer Genomic Testing Market By Product & Service 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents & Consumables
        3. Services
      2. LATAM Lung Cancer Genomic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next Generation Sequencing
        2. Polymerase Chain Reaction
        3. Fluorescence In Situ Hybridization
        4. Microarray
        5. Others
      3. LATAM Lung Cancer Genomic Testing Market By Sample Type 2022-2034 (USD MILLION/ Units)
        1. Tissue Biopsy
        2. Liquid Biopsy
      4. LATAM Lung Cancer Genomic Testing Market By Panel Type 2022-2034 (USD MILLION/ Units)
        1. Multi Gene Panel
        2. Single Gene Panel
      5. LATAM Lung Cancer Genomic Testing Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Centers
        3. Diagnostic Laboratories
        4. Others
      6. Brazil
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      7. Mexico
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      8. Argentina
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      9. Chile
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      10. Colombia
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
      11. Rest of LATAM
        1. Instruments
        2. Reagents & Consumables
        3. Services
        4. Next Generation Sequencing
        5. Polymerase Chain Reaction
        6. Fluorescence In Situ Hybridization
        7. Microarray
        8. Others
        9. Tissue Biopsy
        10. Liquid Biopsy
        11. Multi Gene Panel
        12. Single Gene Panel
        13. Hospitals
        14. Cancer Centers
        15. Diagnostic Laboratories
        16. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.